Vaccine therapy
ABO blood type correlates with survival on prostate cancer vaccine therapy
... Glycan microarray technology is a powerful high- throughput tool for studying interactions of hundreds of carbohydrates with a variety of macromolecules [17–20]. Glycan array assays require only tiny amounts of sera/ ...
13
Live attenuated measles virus vaccine therapy for locally established malignant glioblastoma tumor cells
... Schwarz vaccine strain on glioblastoma multiforme tumor cell lines in ...Schwarz vaccine induces the oncolytic effect in Iraqi tumor cell line ANGM5 and in the rhabdomyosarcoma cell line through syncytia in ...
12
Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma
... MATERIALS AND METHODS: From 2009 to 2012, 21 children, 4 –18 years of age, with diffuse intrinsic pontine gliomas were enrolled in a serial peptide-based vaccination protocol following radiation therapy. DWI was ...
7
FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy
... Thus, we assign the significant increase of FRET efficiency, observed at the membrane surface as a function of time from maturation, to the actual transfer of specific tumor antigen pept[r] ...
6
Leishmaniasis in humans: drug or vaccine therapy?
... pentavalent vaccine with the use of various doses have been conducted in Brazilian army ...the vaccine and placebo ...leishmania vaccine was not broadly used because of difficulty in its production ...
16
Study of the Exogenous Peptide Effect on the TGF-β1 Expression – A Risk Factor for the Hepatocellular Carcinoma Recurrence
... how vaccine therapy with combination of anti-relapse immune correction affects the expression of this factor in patients with HCC, and therefore the possible risk of disease ...
6
Personalized cancer neoantigen vaccines come of age
... of vaccine development is accompanied with ...neoantigen vaccine therapy with other immune therapies or conventional therapies may result in surprisingly synergistic effects on the eradication of ...
9
“Telomeric DNA: New Target For Anticancer Drug Development” by Smita Jain, Neelam Satija, India.
... such vaccine which reached phase III clinical trials ...comparing vaccine therapy with the standard therapy of Gemcitabine and Capecitabine was reported a failure and did not show a ...
10
Prolonged repeated vaccine immuno-chemotherapy induces long-term clinical responses and survival for advanced metastatic melanoma
... (17%), vaccine therapy (18.9%), and cellular therapy (22%) ...(VMCL) vaccine therapy has been reported previously, and the role of the immune system, vaccines and immuno-chemotherapy ...
8
A 15-Year Follow-up of AJCC Stage III Malignant Melanoma Patients Treated Postsurgically with Newcastle Disease Virus (NDV) Oncolysate and Determination of Alterations in the CD8 T Cell Repertoire
... A phase II study initiated in 1975 using adjuvant vaccine therapy composed of allogeneic and autologous human melanoma cells infected with live NDV (NDV oncolysate) in patients with AJCC[r] ...
12
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
... combined vaccine therapy with anti-HER2 treatment among HER2-postive breast cancer ...DC1 vaccine with trastuzumab and pertuzumab in DCIS patients with HER2-positive disease (Table 3; ...DC ...
17
Stage IV gastric cancer successfully treated by multidisciplinary therapy including chemotherapy, immunotherapy, and surgery: a case report
... cell therapy, tumor-pulsed dendritic cell (DC) vaccine therapy, and DC-activated killer cell therapy in the treatment of patients with far-advanced cancer, ei- ther alone or combined with ...
6
The landscape of vaccines in China: history, classification, supply, and price
... acellular vaccine; DTaP-Hib: Diphtheria- tetanus-acellular pertussis combined vaccine and Haemophilus influenza type b conjugate vaccine; DTwP: Diphtheria-tetanus-pertussis whole cell vaccine; ...
8
<p>Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells</p>
... Recent studies have con fi rmed that DRibbles (defective ribosomal products-containing blebs) isolated from tumor cells with the induction of autophagy and inhibition of lysosomal/proteasomal activity are suf fi cient to ...
15
Ontology representation and analysis of vaccine formulation and administration and their effects on vaccine immune responses
... Different vaccine components may share similar functions. For example, vaccine ad- juvant and vaccine conjugate protein both help to induce stronger immune ...A vaccine conjugate protein is ...
15
Primary Immunization of Infants With an Acellular Pertussis Vaccine in a Double-Blind Randomized Clinical Trial
... of adverse reactions to acellular vaccine, whole-cell vaccine, and placebo injections; (2) to evaluate the antibody response to acellular vaccine as compared to a plain whole-cell vaccin[r] ...
9
COOPERATIVE MEASLES VACCINE FIELD TRIAL
... : Inactivated measles virus vaccine, sub- sequent challenge with attenuated live virus. vaccine[r] ...
19
Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame
... circulating vaccine-derived polioviruses (cVDPVs) ...poliovirus vaccine (IPV) for outbreak re- ...immunodeficiency-associated vaccine-derived po- lioviruses (iVDPVs) and (un)intentional releases ...
19
A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens
... antigen vaccine trial, which identified antibodies as a correlate of protection against HSV-1 infection and disease (16, ...bivalent vaccine provided significantly higher neutralizing anti- body titers in ...
13
POLIO: A REVIEW
... In addition to protecting the virus’s genetic material, the capsid proteins enable poliovirus to infect certain types of cells. Three serotypes of poliovirus have been identified-poliovirus type 1 (PV1), type 2 (PV2), ...
11